XML 78 R37.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Feb. 28, 2019
Feb. 28, 2018
Feb. 28, 2017
Sales tax receivables $ 82,992 $ 177,903  
Reduction of research and development expenses 305,592 221,202 $ 148,547
Research and development tax credits received 0 0 88,080
Research and development tax credits receivable 410,997 109,298  
Government grants received 73,581 4,000 0
Government grants receivable 0 73,581 0
Non-cash research and development tax credits 255,975 248,690 25,227
Research and development expense $ 3,448,547 $ 6,694,778 $ 1,454,440
Stock Options      
Dilutive securities 1,962,400 2,374,581 1,010,000
Restricted Stock Units      
Dilutive securities 402,868 34,102 0
Warrants      
Dilutive securities 802,469 140,667 637,670